Oral high-dose glucocorticoids and Ofatumumab in fludarabine-resistant Chronic Lymphocytic Leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2012-05, Vol.26 (5), p.1144-1145
1. Verfasser:	Spaner, D E
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Biological and medical sciences Cancer Research Chronic lymphocytic leukemia Corticosteroids Critical Care Medicine Disease Dosage and administration Dose-Response Relationship, Drug Drug Resistance, Neoplasm Drug therapy Female Fludarabine Glucocorticoids Glucocorticoids - administration & dosage Glucocorticoids - therapeutic use Hematologic and hematopoietic diseases Hematology Humans Immunoglobulins Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphatic leukemia Lymphocytes Male Medical sciences Medicine Medicine & Public Health Middle Aged Multiple sclerosis Ofatumumab Oncology Patients Response rates Transplants & implants Vidarabine - analogs & derivatives Vidarabine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!